Business Context and Reporting Period
Company: Flexible Solutions International Inc. (FSI)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2026
Business Overview: FSI develops and markets biodegradable polymers (TPAs) for the oil, gas, and agriculture industries, as well as energy and water conservation products (EWCP) for swimming pools and irrigation. The company operates primarily in the United States and Canada.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Product Sales | $8,296,997 | $7,473,692 |
| Gross Profit | $1,889,306 | $1,951,564 |
| Gross Margin | 22.8% | 26.1% |
| Operating Loss | $(85,965) | $(69,157) |
| Net Loss (Consolidated) | $(283,357) | $(264,041) |
| Net Loss (Attributable to FSI) | $(241,420) | $(277,734) |
| Cash Used in Operating Activities | $(1,818,177) | $(544,294) |
| Cash and Term Deposits (End of Period) | $6,474,589 | $9,645,257 |
| Total Debt (Current + Long Term) | $9,136,468 | N/A |
| Working Capital | $20,878,345 | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 11.0% year-over-year, driven by increased customer orders in both the EWCP and TPA product lines.
- Margin Compression: Gross margin declined from 26.1% to 22.8%. Management attributes this to increased costs associated with scaling new products, a new manufacturing location, and a higher mix of lower-margin products.
- Operating Expenses: Total operating expenses decreased slightly to $1.98M from $2.02M. This was due to a significant reduction in professional fees (audit fees underaccrued in Q1 2025), partially offset by a 14.7% increase in wages and administrative salaries due to hiring in the TPA division.
- Investment Loss: The company recorded a $54,088 loss from equity method investments, compared to a $63,925 gain in the prior year, as the investee reported a net loss.
- Capital Expenditures: Investing cash outflows surged to $2.23M for property and equipment purchases, compared to $354k in the prior year, reflecting expansion of manufacturing capabilities.
- Debt Utilization: Short-term lines of credit increased significantly from $2.15M to $4.80M to fund operations and capital expenditures.
Outlook, Risks, and Management Commentary
Management Commentary: Management states the company has sufficient cash resources to meet future commitments for the coming year. They do not anticipate significant capital requirements for the twelve months ending March 31, 2027. The company is currently implementing new procedures to remediate material weaknesses in internal controls over financial reporting identified in late 2025, with full remediation expected by Q4 2026.
Key Risks and Contingencies:
- Customer Concentration: Three primary customers accounted for 56% of total sales in Q1 2026 (up from 49% in 2025). One customer (Company A) holds 59% of total accounts receivable ($7.55M).
- Input Costs and Tariffs: Operations are sensitive to crude oil prices (used to manufacture aspartic acid imported from China) and potential new tariffs on raw materials from China.
- Industry Dependence: Future results depend heavily on activity in the oil and gas industry and drought conditions affecting agricultural demand.
- Internal Controls: Disclosure controls and procedures were deemed ineffective as of March 31, 2026, due to material weaknesses in the financial statement close and review process.
- Tax Liabilities: The company recorded income tax expense despite a pre-tax loss, primarily due to accruing interest and penalties on unfiled federal and state tax returns.
Investor Verification Checklist
- Internal Control Remediation: Verify the progress of remediation for the material weaknesses in financial reporting controls and the timeline for effectiveness.
- Tax Compliance: Confirm the status of unfiled federal and state tax returns and the total exposure regarding accrued interest and penalties.
- Customer Concentration: Assess the creditworthiness and contract stability of the top three customers, which represent over half of revenue and a significant portion of receivables.
- Capital Expenditure ROI: Monitor the utilization and revenue generation from the $2.23M in new property and equipment purchases to ensure they offset the margin compression.
- Debt Covenants: Review the terms of the increased short-term lines of credit ($4.8M) to ensure compliance with financial covenants, particularly given the operating losses.